Skip to main content

Amyotrophic Lateral Sclerosis (ALS) UNITE-ALS USNO.24.002

Status: Coming Soon

Study Details

View study details on clinicaltrials.gov.

Locations

  • San Francisco

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Usnoflast Administered to Adult Subjects With ALS UNITE-ALS USNO.24.002

Jonathan Katz
Jonathan Katz
Principal investigator
View Profile

Co-investigator

Liberty Jenkins

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?